Fair Value Measurements (Tables)

12 Months Ended

Dec. 31, 2021

Fair Value Disclosures [Abstract]

Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis

The table below summarizes assets and liabilities measured at fair value on a recurring basis.

			Fair value measurements at reporting date using:
	Gross derivative instruments recorded in the Consolidated Balance Sheets		Quoted prices in active markets  for identical assets (Level 1)		Significant other observable inputs (Level 2)		Significant unobservable inputs (Level 3)
December 31, 2021	(Thousands)
Asset derivative instruments at fair value	$	543,337	$	66,833	$	476,504	$	—
Liability derivative instruments at fair value	2,413,608		126,053		2,287,555		—
December 31, 2020
Asset derivative instruments at fair value	$	527,073	$	70,603	$	456,470	$	—
Liability derivative instruments at fair value	600,877		93,361		507,516		—